PlainRecalls
FDA Drug Low Class III Terminated

Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count bottles (NDC 0093-0058-05), RX only, Manufactured in Czech Republic for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19545

Reported: February 26, 2020 Initiated: January 28, 2020 #D-0851-2020

Product Description

Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count bottles (NDC 0093-0058-05), RX only, Manufactured in Czech Republic for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19545

Reason for Recall

Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
2,044,497 bottles
Distribution
U.S.A. Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b) 500-count bottles (NDC 0093-0058-05), RX only, Manufactured in Czech Republic for: Teva Pharmaceuticals USA, Inc., North Wales, PA 19545. Recalled by Teva Pharmaceuticals USA. Units affected: 2,044,497 bottles.
Why was this product recalled?
Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 26, 2020. Severity: Low. Recall number: D-0851-2020.